about
Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational StudiesTransjugular intrahepatic portosystemic shunts and portal hypertension-related complicationsCancer and liver cirrhosis: implications on prognosis and managementDifferential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosisShear wave elastography results correlate with liver fibrosis histology and liver function reserve.Occult cirrhosis diagnosed by transient elastography is a frequent and under-monitored clinical entity.Integration of Child-Pugh score with future liver remnant yields improved prediction of liver dysfunction risk for HBV-related hepatocellular carcinoma following hepatic resection.Decompensated cirrhosis-related admissions in a large urban hospital in Uganda: prevalence, clinical and laboratory features and implications for planning patient managementClinical relevance of sarcopenia in patients with cirrhosis.Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.Renal dysfunction in patients with cirrhosis: Where do we stand?The clinical challenges of acute on chronic liver failure.Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites.Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI gradeIn-hospital mortality among a cohort of cirrhotic patients admitted to a tertiary hospital.The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection.Differential Clinical Impact of Ascites in Cirrhosis and Idiopathic Portal HypertensionProcoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.Chronic liver disease impairs bacterial clearance in a human model of induced bacteremia.Model for end-stage liver disease: end of the first decade.Serum prolactin in patients with liver disease in comparison with healthy adults: A preliminary cross-sectional studyChallenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint WorkshopDetermination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis.Model for end-stage liver disease score and MELD exceptions: 15 years later.Model for End-Stage Liver Disease and liver cirrhosis-related complications.Interrelationship between insulin resistance and portal haemodynamic abnormality in cirrhosis.Potential use of metabolic breath tests to assess liver disease and prognosis: has the time arrived for routine use in the clinic?Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma.Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study.Factors associated with medication adherence in patients living with cirrhosis.A Dynamic Definition of Acute Kidney Injury Does not Improve Prognosis Assessment in Acutely Decompensated Patients with Cirrhosis.Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure.The prevalence of post-thyroidectomy chronic asthenia: a prospective cohort study.Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.Prognostic significance of insulin-like growth factor-I serum levels in acute decompensation of cirrhosis.Predictive model of mortality in patients with spontaneous bacterial peritonitis.Group B streptococcal bacteremia in non-pregnant adults: results from two Korean centers.The evolution in the prioritization for liver transplantation.
P2860
Q26764798-7EE6F44A-C8F8-4BED-80AE-834A95EEA0B9Q26860685-220D87D7-3BDB-4DB6-A960-1DB23852027EQ28068579-C401A0CF-8ABE-4570-A28A-D6962A1E621EQ28539503-55D87AB3-E726-49F3-A43C-423A4FEE6AA1Q30384025-F309EFA7-2EA4-4154-83CD-E9DC74B582C9Q33420367-6C32E409-C9A9-41DB-9A79-EB6B33CF601AQ33684936-7801BA08-3070-4AB5-B706-31F8200AE95BQ33751594-2271D81E-3FDC-4F68-946D-E4DF8F64865BQ33845474-EF06CC09-EB13-4C24-9CBC-DCDC570F23F3Q33865883-8C7A4391-2D82-4114-A4F6-65531148A552Q34047665-43379180-232B-4932-8530-A0600A7B2183Q34206604-2EB22F77-C56F-4D9E-BDFD-6321D6B27D94Q34208316-E2E1343F-A87A-4420-8F56-FF7160732700Q35065472-5A197CE1-0C15-4C34-A0F8-DEB315A77FAEQ35564318-1EAB60E4-FCDD-4D08-83BB-FB9A2E6ADE73Q35590977-D70EFD89-D08E-4F90-B63E-5D641B7F9EEBQ35857858-35D0D553-941D-43E7-8650-70C3A21508AFQ35911484-B648FE13-BE31-4F8F-8481-4D5AC8C08706Q36152726-26D8F8E2-6CDB-4294-BD55-558FAE79E2BEQ36588122-A15A5D40-EDDF-40D0-B575-CB9EEB6AB73CQ36612174-0188B7B9-82C3-4C79-B7EC-3FC0D4ED9909Q36987260-203556AF-1EAF-44C0-BD4A-8539B3AF5ACFQ38368635-85BC4E70-FCAC-4DAF-8C75-7367605CE4A5Q38460185-8301176D-DFCF-49EA-9476-592432A32363Q38504284-8DFD4432-415A-4F8A-9614-732C5F7FB8E2Q38552232-14462CF2-AE70-44B8-ACAE-F4DAFBC7F0A7Q38861634-545A3729-A3FF-4F66-B9D3-3FF8837661ABQ38975618-4D692D8F-C718-44FD-A250-E6122569B13AQ39452131-C86698A2-6CBE-4CC1-8752-E28CD7FF0AFEQ39743925-720DA115-4135-4DE9-92E7-DA9BE5C348DCQ40066371-36E90B8E-3780-4D90-A8B0-DD1F4C368C41Q40106356-05B426FF-01A3-448F-BC08-E25F82BD5CFBQ40140446-7CEEE310-AE62-46ED-A3CC-1B24A51FA09FQ40160320-4861BF8F-4344-4BBE-BD0D-2FF0171A93B5Q40290152-8C118722-2C30-4929-A891-BE8112C50003Q40311999-32B6F608-D9BE-48F8-9248-1C4D84E5AB67Q40520313-25AEE1E4-D840-4A29-9256-8181E9EFC7CFQ40597812-8996CBEC-340A-41C7-B43A-751E8FCF98D6Q42215412-7D6756F0-ADCA-4ADA-BF84-26C29BFED1FAQ42406771-9F289973-F4DD-4EA8-BE05-93E4453EED22
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Assessment of prognosis of cirrhosis.
@en
Assessment of prognosis of cirrhosis.
@nl
type
label
Assessment of prognosis of cirrhosis.
@en
Assessment of prognosis of cirrhosis.
@nl
prefLabel
Assessment of prognosis of cirrhosis.
@en
Assessment of prognosis of cirrhosis.
@nl
P356
P1476
Assessment of prognosis of cirrhosis
@en
P2093
Dominique Valla
François Durand
P304
P356
10.1055/S-2008-1040325
P577
2008-02-01T00:00:00Z